Cargando…

How to Monitor Cardiac Complications of Immune Checkpoint Inhibitor Therapy

Immune-checkpoint inhibitors (ICIs) represent a successful paradigm in the treatment of cancer. ICIs elicit an immune response directed against cancer cells, by targeting the so-called immune checkpoints, key regulators of the immune system that when stimulated can dampen the immune response to an i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spallarossa, Paolo, Sarocchi, Matteo, Tini, Giacomo, Arboscello, Eleonora, Toma, Matteo, Ameri, Pietro, Porto, Italo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333217/ https://www.ncbi.nlm.nih.gov/pubmed/32676031 http://dx.doi.org/10.3389/fphar.2020.00972

Ejemplares similares

Diversity of Cardiologic Issues in a Contemporary Cohort of Women With Breast Cancer
por: Tini, Giacomo, et al.
Publicado: (2021)

Cardiac metastasis presenting with an ischaemic electrocardiogram pattern mimicking anterior myocardial infarction
por: Travaglio, Nicole, et al.
Publicado: (2018)

Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism
por: Masini, Marta, et al.
Publicado: (2023)

Cancer Patient With Unusual Dyspnea in the COVID-19 Era: Challenging Management of a Rare Cardiac Tumor
por: La Malfa, Giovanni, et al.
Publicado: (2021)

An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline
por: Sarocchi, Matteo, et al.
Publicado: (2018)

Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies
por: Tini, Giacomo, et al.
Publicado: (2023)

Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19
por: De Marzo, Vincenzo, et al.
Publicado: (2021)

A Score-Based Approach to (18)F-FDG PET Images as a Tool to Describe Metabolic Predictors of Myocardial Doxorubicin Susceptibility
por: Bauckneht, Matteo, et al.
Publicado: (2017)

Exploring the influence of takotsubo syndrome on oncologic patients’ mortality
por: Tini, Giacomo, et al.
Publicado: (2022)

Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature
por: Boutros, A., et al.
Publicado: (2023)

Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC)
por: Mercurio, Valentina, et al.
Publicado: (2020)

Multiparametric vs. Inferior Vena Cava–Based Estimation of Right Atrial Pressure
por: Toma, Matteo, et al.
Publicado: (2021)

Cardiac toxicity of trastuzumab in elderly patients with breast cancer
por: Denegri, Andrea, et al.
Publicado: (2016)

Sacubitril/valsartan in real‐life European patients with heart failure and reduced ejection fraction: a systematic review and meta‐analysis
por: Giovinazzo, Stefano, et al.
Publicado: (2021)

Mechanical circulatory support in patients with cardiogenic shock not secondary to cardiotomy: a network meta-analysis
por: Benenati, Stefano, et al.
Publicado: (2021)

Impact of bioprosthetic valve type on peri-procedural myocardial injury and mortality after transcatheter aortic valve replacement
por: De Marzo, Vincenzo, et al.
Publicado: (2021)

Diagnostic yield and predictive value on left ventricular remodelling of genetic testing in dilated cardiomyopathy
por: Bertero, Edoardo, et al.
Publicado: (2023)

Not Every ST-Segment Elevation Is a STEMI
por: Merlo, Andrea C., et al.
Publicado: (2021)

Type 2 myocardial infarction: a diagnostic and therapeutic challenge in contemporary cardiology
por: Merlo, Andrea Carlo, et al.
Publicado: (2022)

Cardiac arrhythmias associated with immune checkpoint inhibitors: A comprehensive disproportionality analysis of the FDA adverse event reporting system
por: Wang, Feifei, et al.
Publicado: (2022)

Beneficial Effect of Phenytoin and Carbamazepine on GFAP Gene Expression and Mutant GFAP Folding in a Cellular Model of Alexander’s Disease
por: Bachetti, Tiziana, et al.
Publicado: (2021)

Personalized Medicine of Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacogenetics, Therapeutic Drug Monitoring, and Beyond
por: Di Paolo, Antonello, et al.
Publicado: (2021)

Toxicity of Immune-Checkpoint Inhibitors in Hematological Malignancies
por: Hradska, Katarina, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in Peripheral T-Cell Lymphoma
por: Chen, Xi, et al.
Publicado: (2022)

Clinical Insights Into Novel Immune Checkpoint Inhibitors
por: Lee, Jii Bum, et al.
Publicado: (2021)

Resistance to immune checkpoint inhibitors in gastric cancer
por: Liu, Kai, et al.
Publicado: (2023)

Hyperprogressive Disease in Cancers Treated With Immune Checkpoint Inhibitors
por: Shen, Pan, et al.
Publicado: (2021)

Drug therapy for myocarditis induced by immune checkpoint inhibitors
por: Wu, Yihao, et al.
Publicado: (2023)

Neurologic Toxicity of Immune Checkpoint Inhibitors: A Review of Literature
por: Albarrán, Víctor, et al.
Publicado: (2022)

The Strategies and Mechanisms of Immune Checkpoint Inhibitors for Brain Metastases in NSCLC
por: Li, Ji, et al.
Publicado: (2022)

Immune checkpoint inhibitors in osteosarcoma: A hopeful and challenging future
por: Zhang, Zeng, et al.
Publicado: (2022)

Complicated Complication: How Interventional Radiologists Should Manage Acute Iatrogenic Cardiac Tamponade
por: Harmon, Taylor S, et al.
Publicado: (2018)

Alzheimer's Disease and Cardiovascular Disease: A Particular Association
por: Tini, Giacomo, et al.
Publicado: (2020)

Prognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New Evidences
por: Yan, Xinyu, et al.
Publicado: (2018)

PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
por: Liu, Jinhua, et al.
Publicado: (2021)

Adverse Effects and Toxicity of Immune Checkpoint Inhibitors For Patients With Urothelial Carcinoma
por: Wang, Di, et al.
Publicado: (2021)

Cardiotoxicity associated with immune checkpoint inhibitors: Current status and future challenges
por: Gan, Lu, et al.
Publicado: (2022)

Potential role of gut microbes in the efficacy and toxicity of immune checkpoints inhibitors
por: Ma, Jingxin, et al.
Publicado: (2023)

How we treat endocrine complications of immune checkpoint inhibitors
por: Paschou, S.A., et al.
Publicado: (2021)

How to Prevent or Reduce Prescribing Errors: An Evidence Brief for Policy
por: de Araújo, Bruna Carolina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_49t4g8fla3k6av00qpdv1uf2ai